Transthyretin-mediated Amyloidosis
3 clinical trials · Condition
◉ Watch Transthyretin-mediated Amyloidosis
| Record | Firm | Date |
|---|---|---|
| ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) (NCT04561518) | Alnylam Pharmaceuticals | 2020-11-23 |
Track Transthyretin-mediated Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.